Eli Lilly

Eli Lilly announced that it will cap the cost of insulin at $35 a month. This is a huge deal that will improve the lives of millions of Americans. How do you share this message so that people can appreciate how President Biden’s bold action will help them and others in the county where they live? …

Drugmaker Eli Lilly is cutting prices for its insulin and capping costs at $35 per month — Eli Lilly is reducing prices for insulin and capping the costs at $35 per month. Out-of-pocket expenses will not exceed this amount for those with commercial insurance using Lilly insulin. People without insurance may still be able to get help through a savings card program. The company is also cutting…

Sorry diabetic folks, you thought a corporation would actually do something right for once? Wrong. Imagine explaining this situation to your past self 3–4 years ago. “One of the richest guy’s in the world bought a company with a teenagers understanding of free speech, overpaid for it heavily, and attempted…

At Top Gun Options we pay attention to domestic and foreign actors in order to stay ahead of changes in the markets. The usual focus of our attention is the acronym DRINC which stands for Democrats, Russia, Iran, North Korea, and China, all of whom have caused more than their…

Obit: Howard Bowen, 58, Local Man Who Discovered New York Yankees Aaron Judge Ben Edokpayi, Sports Reporter Word Count 1631 Dixon-Calif: A bad kidney has ended the sky-high aspirations of Howard Bowen, the local scout who helped discover the 2017 MLB rookie of the year, New York Yankees Aaron Judge. …

A Bloody Mess! Is WWIII Inevitable Because of Extreme Medical Privacy Violations And Unbelievable Anatomical Distortions? Exclusive Insider Report By Ben Edokpayi, the Oracle Ward Count 893 Dumb Xenophobes and Racists (Sims There Are Millions Out There) How Does Rectal Bleeding between 09–11 From Food Poison Make Me Gay? …

Shorter Path to Market Eli Lilly & Co. announced on August 17 that it will split its Lilly Bio-Medicines division into two business units: Lilly Neuroscience and Lilly Immunology, effective September 5, reported Tonya Garcia in MarketWatch. …

Changing Course In April, a top company executive at Eli Lilly told investors that Lilly did not anticipate submitting its experimental Alzheimer’s medicine donanemab for an accelerated approval based on the clinical trial evidence it had accrued. Then, the FDA “controversially cleared Biogen’s Alzheimer’s drug Aduhelm on a conditional basis…

Lilly continues to build out its oncology brand pharmaceutical franchise with new Cyramza indications — John G. Baresky The U.S. Food and Drug Administration (FDA) has approved Cyramza (ramucirumab injection, 10 mg/mL solution), in combination with erlotinib for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 (L858R) mutations. …